Study of a new treatment for bunions
Part of Bones, joints & muscles, Pain clinical trials.
This study tests a new treatment for bunions to see if it works well and is safe. If you have a bunionabbess, this trial might help improve your foot pain and function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a bunion (a bony bump at the base of your big toe).
- You must not have other medical conditions that could affect the study results.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new pain medicine given during bunion surgery to see how well it controls pain after the operation. It may reduce the need for other painkillers.
This study tests a new nerve-blocking medication (ALX006) injected near the sciatic nerve to reduce pain after bunion surgery. The goal is to see if it provides better pain relief compared to standard care.
This trial tests an investigational medicine called GRT7040 to see if it can reduce pain after bunion surgery. You would receive the study drug or a placebo after your surgery, and the study team will monitor your pain levels.
This trial tests an investigational pain medicine for people who have moderate to severe pain after bunion removal surgery. The goal is to see if it relieves pain better than a placebo.
This trial compares two approaches for treating mild-to-moderate bunion pain: surgery versus non-surgical options like wearing wider shoes, toe spacers, or physical therapy. The goal is to see which works better for relieving pain and improving daily life.
This trial studies results after a combined bunion and forefoot alignment surgery to improve foot shape and function. It may help people whose foot angles show significant bunion and front-of-foot deformity.
Hear when a new Postoperative Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.